Use of Psychotropic Drugs and Alcohol among Non-Institutionalised Elderly Adults in Germany

 

 Buy Article Permissions and Reprints

Abstract

Introduction: Little is known about the use of psychotropic drugs and alcohol among non-institutionalised elderly adults in Germany.

Methods: Using data from the 1998 German National Health Interview and Examination Survey, we analysed patterns of current psychotropic drug and alcohol use among 726 male and 879 female survey participants between the ages of 60 and 79. Multivariable regression analysis was used to determine factors associated with alcohol consumption and psychotropic drug use.

Results: The overall weighted last-week prevalence was 20.1% for the use of psychotropic drugs, 47.3% for the use of alcohol, 15.1% for risky drinking, and 7.6% for combined psychotropic drug and alcohol use. Factors significantly related to psychotropic drug use included female sex, older age, poor health status and polypharmacy. Male sex, smoking, higher social status, better health status and living alone were determinants of alcohol consumption.

Conclusions: Compared to other European countries, overall psychotropic drug use among the elderly in Germany is slightly lower, whereas alcohol use as risky drinking and concurrent use of alcohol and psychotropic drugs are highly prevalent. It should be of particular concern to health professionals that people at high risk for psychotropic drug use include the most vulnerable subgroups among the elderly.

References

• 1 Adams WL. Potential for adverse drug-alcohol interactions among retirement community residents.  J Am Geriatr Soc. 1995;  43 1021-1025
  PubMedGoogle Scholar
• 2 Alonso J, Angermeyer MC, Bernert S. et al . Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.  Acta Psychiatr Scand Suppl. 2004;  420 55-64
  PubMedGoogle Scholar
• 3 Angermeyer MC, Matschinger H. Public attitudes towards psychotropic drugs: have there been any changes in recent years?.  Pharmacopsychiatry. 2004;  37 152-156
  Article in Thieme ConnectPubMedGoogle Scholar
• 4 Antonijoan RM, Barbanoj MJ, Torrent J. et al . Evaluation of psychotropic drug consumption related to psychological distress in the elderly: hospitalized vs.  nonhospitalized. Neuropsychobiology. 1990;  23 25-30
  PubMedGoogle Scholar
• 5 Aparasu R, Mort J, Brandt H. Psychotropic medication expenditures for community-dwelling elderly persons.  Psychiatr Serv. 2003;  54 739-742
  CrossrefPubMedGoogle Scholar
• 6 Aparasu RR, Mort JR, Brandt H. Psychotropic prescription use by community-dwelling elderly in the United States.  J Am Geriatr Soc. 2003;  51 671-677
  CrossrefPubMedGoogle Scholar
• 7 Bellach B, Knopf H, Thefeld W. Der Bundes-Gesundheitssurvey 1997/98 (The National Health Survey 1997/98).  Gesundheitswesen. 1998;  60 ((special issue 2)) 59-68
  PubMedGoogle Scholar
• 8 Benkert O, Graf-Morgenstern M, Hillert A. et al . Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection.  J Nerv Ment Dis. 1997;  185 151-158
  CrossrefPubMedGoogle Scholar
• 9 Blazer DG, Hybels CF, Simonsick EM. et al . Marked differences in antidepressant use by race in an elderly community sample: 1986–1996.  Am J Psychiat. 2000;  157 1089-1094
  PubMedGoogle Scholar
• 10 Burger M, Bronstrup A, Pietrzik K. Derivation of tolerable upper alcohol intake levels in Germany: a systematic review of risks and benefits of moderate alcohol consumption.  Prev Med. 2004;  39 111-127
  CrossrefPubMedGoogle Scholar
• 11 Burger M, Mensink G, Bronstrup A. et al . Alcohol consumption and its relation to cardiovascular risk factors in Germany.  Eur J Clin Nutr. 2004;  58 605-614
  CrossrefPubMedGoogle Scholar
• 12 Burger M, Mensink GB. High alcohol consumption in Germany: results of the German National Health Interview and Examination Survey 1998.  Public Health Nutr. 2004;  7 879-884
  PubMedGoogle Scholar
• 13 Burggraf GW. Are psychotropic drugs at therapeutic levels a concern for cardiologists?.  Can J Cardiol. 1997;  13 75-80
  PubMedGoogle Scholar
• 14 Lima McS de, Dunn J, Novo IP. et al . Gender differences in the use of alcohol and psychotropics in a Brazilian population.  Subst Use Misuse. 2003;  38 51-65
  CrossrefPubMedGoogle Scholar
• 15 Dealberto MJ, Seeman T, MacAvay GJ. et al . Factors related to current and subsequent psychotropic drug use in an elderly cohort.  J Clin Epidemiol. 1997;  50 357-364
  CrossrefPubMedGoogle Scholar
• 16 Fick DM, Cooper JW, Wade WE. et al . Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.  Arch Intern Med. 2003;  163 2716-2724
  CrossrefPubMedGoogle Scholar
• 17 Field TS, Gurwitz JH, Harrold LR. et al . Risk factors for adverse drug events among older adults in the ambulatory setting.  J Am Geriatr Soc. 2004;  52 1349-1354
  CrossrefPubMedGoogle Scholar
• 18 Gleason PP, Schulz R, Smith NL. et al . Correlates and prevalence of benzodiazepine use in community-dwelling elderly.  J Gen Intern Med. 1998;  13 243-250
  CrossrefPubMedGoogle Scholar
• 19 Gustafsson TM, Isacson DGL, Thorslund M. et al . Factors associated with psychotropic drug use among the elderly living at home.  J Appl Gerontol. 1996;  15 238-254
  CrossrefPubMedGoogle Scholar
• 20 Hansen DG, Rosholm JU, Gichangi A. et al . Increased use of antidepressants at the end of life: population-based study among people aged 65 years and above.  Age Ageing. 2007;  36 449-454
  CrossrefPubMedGoogle Scholar
• 21 Harrington C, Tompkins C, Curtis M. et al . Psychotropic drug use in long-term care facilities: a review of the literature.  Gerontologist. 1992;  32 822-833
  PubMedGoogle Scholar
• 22 Heckman GA, Misiaszek B, Merali F. et al . Association between psychotropic drug use and heart failure therapy in elderly long-term care residents.  J Am Geriatr Soc. 2006;  54 1973-1975
  CrossrefPubMedGoogle Scholar
• 23 Hoffmeister H, Schelp FP, Mensink GB. et al . The relationship between alcohol consumption, health indicators and mortality in the German population.  Int J Epidemiol. 1999;  28 1066-1072
  CrossrefPubMedGoogle Scholar
• 24 Ilomäki J, Korhonen MJ, Enlund H. et al . Risk drinking behavior among psychotropic drug users in an aging Finnish population: The FinDrink study.  Alcohol. 2008;  , in press, corrected proof
  PubMedGoogle Scholar
• 25 John U, Baumeister SE, Volzke H. et al . Sedative, hypnotic, anxiolytic and opioid medicament use and its co-occurrence with tobacco smoking and alcohol risk drinking in a community sample.  BMC Public Health. 2007;  7 337
  CrossrefPubMedGoogle Scholar
• 26 Kessler RC, Merikangas KR. The National Comorbidity Survey Replication (NCS-R): background and aims.  Int J Methods Psychiatr Res. 2004;  13 60-68
  CrossrefPubMedGoogle Scholar
• 27 Kirby M, Denihan A, Bruce I. et al . Benzodiazepine use among the elderly in the community.  Int J Geriatr Psychiatry. 1999;  14 280-284
  CrossrefPubMedGoogle Scholar
• 28 Kraus L, Bloomfield K, Augustin R. et al . Prevalence of alcohol use and the association between onset of use and alcohol-related problems in a general population sample in Germany.  Addiction. 2000;  95 1389-1401
  CrossrefPubMedGoogle Scholar
• 29 Kunig G, Datwyler S, Eschen A. et al . Unrecognised long-lasting tramadol-induced delirium in two elderly patients. A case report.  Pharmacopsychiatry. 2006;  39 194-199
  Article in Thieme ConnectPubMedGoogle Scholar
• 30 Lee KC, Finley PR, Alldredge BK. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings.  Expert Opin Drug Saf. 2003;  2 233-247
  CrossrefPubMedGoogle Scholar
• 31 Linden M, Bar T, Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE).  Int Psychogeriatr. 2004;  16 461-480
  CrossrefPubMedGoogle Scholar
• 32 Linjakumpu T, Hartikainen S, Klaukka T. et al . Psychotropics among the home-dwelling elderly – increasing trends.  Int J Geriatr Psychiatry. 2002;  17 874-883
  CrossrefPubMedGoogle Scholar
• 33 Madhusoodanan S, Bogunovic OJ. Safety of benzodiazepines in the geriatric population.  Expert Opin Drug Saf. 2004;  3 485-493
  CrossrefPubMedGoogle Scholar
• 34 Meyer C, Rumpf HJ, Hapke U. et al . Prevalence of alcohol consumption, abuse and dependence in a country with high per capita consumption: findings from the German TACOS study. Transitions in Alcohol Consumption and Smoking.  Soc Psychiatry Psychiatr Epidemiol. 2000;  35 539-547
  PubMedGoogle Scholar
• 35 Mirand AL, Welte JW. Alcohol consumption among the elderly in a general population, Erie County, New York.  Am J Public Health. 1996;  86 978-984
  CrossrefPubMedGoogle Scholar
• 36 Moore AA, Whiteman EJ, Ward KT. Risks of combined alcohol/medication use in older adults.  Am J Geriatr Pharmacother. 2007;  5 64-74
  CrossrefPubMedGoogle Scholar
• 37 Ohayon MM, Caulet M, Priest RG. et al . Psychotropic medication consumption patterns in the UK general population.  J Clin Epidemiol. 1998;  51 273-283
  CrossrefPubMedGoogle Scholar
• 38 Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.  J Clin Psychiatry. 2002;  63 817-825
  PubMedGoogle Scholar
• 39 Paterniti S, Dufouil C, Bisserbe JC. et al . Anxiety, depression, psychotropic drug use and cognitive impairment.  Psychol Med. 1999;  29 421-428
  CrossrefPubMedGoogle Scholar
• 40 Paulose-Ram R, Jonas BS, Orwig D. et al . Prescription psychotropic medication use among the U.S. adult population: results from the third National Health and Nutrition Examination Survey, 1988–1994.  J Clin Epidemiol. 2004;  57 309-317
  CrossrefPubMedGoogle Scholar
• 41 Percudani M, Barbui C, Fortino I. et al . Antipsychotic drug prescribing in the elderly is cause for concern.  Int Clin Psychopharmacol. 2004;  19 347-350
  CrossrefPubMedGoogle Scholar
• 42 Pringle KE, Ahern FM, Heller DA. et al . Potential for alcohol and prescription drug interactions in older people.  J Am Geriatr Soc. 2005;  53 1930-1936
  CrossrefPubMedGoogle Scholar
• 43 Schwab M, Roder F, Aleker T. et al . Psychotropic drug use, falls and hip fracture in the elderly.  Aging (Milano). 2000;  12 234-239
  PubMedGoogle Scholar
• 44 Simoni-Wastila L, Yang HK. Psychoactive drug abuse in older adults.  Am J Geriatr Pharmacother. 2006;  4 380-394
  CrossrefPubMedGoogle Scholar
• 45 Simoni-Wastila L, Zuckerman IH, Singhal PK. et al . National estimates of exposure to prescription drugs with addiction potential in community-dwelling elders.  Subst Abus. 2005;  26 33-42
  PubMedGoogle Scholar
• 46 Sonntag A, Matschinger H, Angermeyer MC. et al . Does the context matter? Utilization of sedative drugs in nursing homes – a multilevel analysis.  Pharmacopsychiatry. 2006;  39 142-149
  Article in Thieme ConnectPubMedGoogle Scholar
• 47 Steinman MA, Landefeld CS, Rosenthal GE. et al . Polypharmacy and prescribing quality in older people.  J Am Geriatr Soc. 2006;  54 1516-1523
  CrossrefPubMedGoogle Scholar
• 48 Swartz M, Landerman R, George LK. et al . Benzodiazepine anti-anxiety agents: prevalence and correlates of use in a southern community.  Am J Public Health. 1991;  81 592-596
  PubMedGoogle Scholar
• 49 Taylor S, MacCracken CF, Wilson KC. et al . Extent and appropriateness of benzodiazepine use. Results from an elderly urban community.  Br J Psychiatry. 1998;  173 433-438
  CrossrefPubMedGoogle Scholar
• 50 The WHO World Mental Health Survey Consortium . Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.  JAMA. 2004;  291 2581-2590
  CrossrefPubMedGoogle Scholar
• 51 Ufer M, Meyer SA, Junge O. et al . Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis.  Pharmacoepidemiol Drug Saf. 2007;  16 1153-1160
  CrossrefPubMedGoogle Scholar
• 52 Voyer P, Cohen D, Lauzon S. et al . Factors associated with psychotropic drug use among community-dwelling older persons: a review of empirical studies.  BMC Nurs. 2004;  31 3
  PubMedGoogle Scholar
• 53 Weyerer S, Dilling H. Psychiatric and physical illness, sociodemographic characteristics, and the use of psychotropic drugs in the community: results from the upper Bavarian field study.  J Clin Epidemiol. 1991;  44 303-311
  CrossrefPubMedGoogle Scholar

Correspondence

Y. DuPhD 

RKI 22

Department of Epidemiology and Health Monitoring

Division of Non-Communicable Disease Epidemiology

Robert Koch-Institute

Seestr. 10

13353 Berlin

Germany

Phone: +49/30/4547 31 99

Fax: +49/30/4547 32 11

Email: DuY@rki.de